Eight genetic gifts we received this year

2025-01-12T08:37:47+00:0020 December 2024|

What has genetics done for us? Well in 2024, it paved the way for better cancer treatment, supported conservation efforts and mapped the hidden world of connections in our bodies to name but three. So, sit back as we unwrap eight gifts that genetics at the Sanger Institute has provided this year.

Unlocking the genetics of skin cancer

2024-11-12T11:17:26+00:0012 November 2024|

Dr David Adams, Senior Group Leader at the Wellcome Sanger Institute, is a pioneer in cancer biology and uncovering skin cancer genetics. We explore his 20-year career at Sanger and the global impact of his research.

The architecture of disease

2024-10-09T09:52:41+01:009 October 2024|

Our photo essay features some of the people behind the cutting-edge cancer research at the Sanger Institute. With genomic techniques now able to uncover the DNA sequence and structure in millions individual cells, they are uncovering the genetic architecture of disease.

Personalising cancer treatment using the gut microbiome

2024-09-06T10:23:10+01:006 September 2024|

Did you know that your gut bugs may affect your cancer risk? Dr Ashray Gunjur, Clinical Research Training Fellow at the Wellcome Sanger Institute, is exploring how clinicians can use the biology of the gut microbiome to personalise cancer treatment.

Celebrating COSMIC and 20 years of enhancing cancer research

2024-08-07T11:55:13+01:002 August 2024|

In 2024, COSMIC – the world’s largest and most comprehensive resource on genetic mutations in cancer – celebrates two exciting milestones: COSMIC reaches its 20th anniversary and releases its 100th version of the database.

COSMIC: CASE STUDY

2026-10-23T15:08:20+01:0010 January 2024|

COSMIC is an online catalogue of somatic mutations in cancer, a gold standard data resource of global impact in the field of cancer genomics. The database has utility for basic research into the mechanisms of cancer but is also relevant for pharmaceutical R&D activities in oncology as well as the development of products and services in cancer diagnosis and patient stratification.

One childhood cancer, one thousand children: landmark genomic study delivers first discoveries

2024-05-21T14:56:58+01:0025 September 2023|

Tumours from 1000 children with kidney cancer have been sequenced, thanks to the Little Princess Trust and researchers at the Wellcome Sanger Institute. The Little Princess Trust ‘Knowledge Bank’ is the largest comprehensive genomics resource for any childhood solid tumour, and is already being used for research to understand childhood cancers.